Brief: Chai Discovery Announces License Agreement With Pfizer To Accelerate Drug Discovery With AI
04/06/2026 15:51
BRIEF-Chai Discovery Announces License Agreement With Pfizer To Accelerate Drug Discovery With AI June 4 (Reuters) - Chai Discovery:
CHAI DISCOVERY ANNOUNCES LICENSE AGREEMENT WITH PFIZER TO ACCELERATE DRUG DISCOVERY WITH AI
CHAI DISCOVERY: PFIZER SCIENTISTS WILL LEVERAGE CHAI DISCOVERY'S AI PLATFORM TO HELP ACCELERATE DRUG DISCOVERY RESEARCH
Source text: ID:nBw3GqPlqa
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pfizer
See all newsU.S. STOCKS ON THE MOVE-Chip stocks, Unicycive, Roblox
U.S. STOCKS ON THE MOVE-AMD, Roblox, Olin
Eli Lilly, Pfizer slip after US House panel probing China clinical trials
US House committee opens investigation into Merck, AbbVie China drug trials (updated)
Brief: U.S. House Committee Sends Letters To Pfizer, Eli Lilly & Bristol Myers Squibb Probing China Drug Trials